Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Catherine Legras-Lachuer
Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
Frontiers in Immunology
Allergy
Immunology
Related publications
Repurposing Clinical Drugs as AdoMetDC Inhibitors Using the SCAR Strategy
Frontiers in Pharmacology
Pharmacology
Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza a Virus Replication
Assay and Drug Development Technologies
Drug Discovery
Molecular Medicine
Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses
Angewandte Chemie - International Edition
Catalysis
Chemistry
Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection
Frontiers in Microbiology
Microbiology
Gene Expression Signatures as a Therapeutic Target for Severe H7N9 Influenza – What Do We Know So Far?
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
New Drug Candidates for Treatment of Atypical Meningiomas: An Integrated Approach Using Gene Expression Signatures for Drug Repurposing
PLoS ONE
Multidisciplinary
Possible Repurposing of Seasonal Influenza Vaccine for Prevention of Zika Virus Infection
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
Drugs
Pharmacology
Furan-Carboxamide Derivatives as Novel Inhibitors of Lethal H5N1 Influenza a Viruses
RSC Advances
Chemistry
Chemical Engineering